Quantcast
Channel: OneMedPlace - Sentinel313
Browsing all 6 articles
Browse latest View live

http://www.onemedplace.com/blog/wp-content/uploads/2009/08/neopharm.jpg

NeoPharm, a biopharmaceutical company developing drugs for cancer treatment, has been tipped as a worthwhile stock on financial website Seeking Alpha.

View Article



http://www.onemedplace.com/blog/wp-content/uploads/2009/08/tedkennedy.jpg

Glioblastoma multiforme (GBM), the aggressive brain tumor that took Sen. Kennedy's life, is one of the deadliest brain tumors that can occur in both adults and children.

View Article

http://www.onemedplace.com/blog/wp-content/uploads/2009/09/cancerdrugs.jpg

On 10/19/09, BioElectronics (OTC: BIEL.PK) announced the initial results from the pilot section of its ongoing acetaminophen comparison study.

View Article

http://www.onemedplace.com/blog/wp-content/uploads/2009/07/lungs-small.jpg

The drug candidate IL13-PE has the potential to be the first effective therapy for idiopathic pulmonary fibrosis (IPF), which kills an estimated 40,000 people in the United States each year.

View Article

http://www.onemedplace.com/blog/wp-content/uploads/2010/03/lungs.jpg

The recommendation caused a 64 percent jump in InterMune stock prices and fueled speculation that the Brisbane, Calif.-based company is ripe for acquisition.

View Article


http://www.onemedplace.com/blog/wp-content/uploads/2010/07/handshake2.jpg

Celgene has acquired Abraxis BioScience in a cash-and-stock deal valued at $2.9 billion, reports FierceBiotech.

View Article
Browsing all 6 articles
Browse latest View live




Latest Images